Search results

Found 48 pages
AUTHOR: Michael Day

Results per page

10 20 50 100

Sort by

Relevance Date

24 Aug 2007:

NICE is actually far too generous, claims health economist

The National Institute for Health and Clinical Excellence (NICE) allows too many expensive treatments to be available on the NHS, rather than too few, health economists claim in this week’s British Medical Journal. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/nice_is_actually_far_too_generous,_claims_health_economist_990712

1 Aug 2007:

Tear up plans for fertility legislation, gov't told

An influential parliamentary committee has called on the British government to tear up proposed legislation on fertility research and regulation and start again. The call came from the Joint Committee on the Draft Human Tissue and Embryos Bill, as

by Michael Day

https://www.pharmatimes.com/news/tear_up_plans_for_fertility_legislation,_govt_told_990535

3 Sep 2007:

Rasilez data takes centre-stage at ESC meeting in Vienna

The first in a new class of antihypertensives in over a decade can lower blood pressure by up to 50% when combined with other treatments, and may have key advantages for heart failure patients, according to new research. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/rasilez_data_takes_centre-stage_at_esc_meeting_in_vienna_990764

25 Apr 2008:

Gilead's HIV drug Viread gets EU approval for hepatitis B

As a leading hepatologist has revealed more good news for Gilead's HIV-turned-hepatitis B treatment Viread (tenofovir), the drug received European approval for treating the liver disease - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/gileads_hiv_drug_viread_gets_eu_approval_for_hepatitis_b_987200

12 Mar 2009:

WHO angry at seizure by Dutch of HIV drug shipment

The World Health Organisation has condemned the Dutch Government’s “farcical” detention of HIV medication destined for Sub-Saharan Africa, which it says flouts world trade rules – and will endanger patients’ health. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/who_angry_at_seizure_by_dutch_of_hiv_drug_shipment_985291

28 Mar 2008:

Ferring's degarelix offers exciting option for prostate cancer

A leading cancer surgeon has described Ferring's new prostate cancer drug degarelix, as a "breakthrough" on the basis of fresh Phase III results. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/ferrings_degarelix_offers_exciting_option_for_prostate_cancer_987403

28 May 2008:

Cancer Research to join with pharma to crack cancer medicine questions

Cancer Research UK has announced a series of academic-business ventures aimed at cracking some of the most pressing questions in cancer medicine. It is now seeking a pharmaceutical industry partner for the first of three joint ventures to work with

by Michael Day

https://www.pharmatimes.com/news/cancer_research_to_join_with_pharma_to_crack_cancer_medicine_questions_986975

26 Aug 2008:

Is NICE looking for more influence in new drug pricing plan?

An unprecedented attack last week on pharmaceutical prices by the National Institute for Health and Clinical Excellence chairman Michael Rawlins, signals a controversial new role for the UK health watchdog in the forthcoming overhaul of drugs pricing

by Michael Day

https://www.pharmatimes.com/news/is_nice_looking_for_more_influence_in_new_drug_pricing_plan_988000